Efficacy of STI571, an Abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against Bcr-Abl-positive cells

J. Tyler Thiesing, Sayuri Ohno-Jones, Kathryn S. Kolibaba, Brian J. Druker

Research output: Contribution to journalArticlepeer-review

314 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy of STI571, an Abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against Bcr-Abl-positive cells'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences